High-throughput urine screening for Smith–Lemli–Opitz syndrome and cerebrotendinous xanthomatosis using negative electrospray tandem mass spectrometry

This publication has 16 references indexed in Scilit:

• Maternal urinary steroid profiles in prenatal diagnosis of Smith–Lemli–Opitz syndrome: first patient series comparing biochemical and molecular studies
  Clinical Genetics, 2005
• Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-Δ7-reductase deficiency (Smith–Lemli–Opitz syndrome)
  The Journal of Steroid Biochemistry and Molecular Biology, 2002
• Dehydro-oestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith-Lemli-Opitz syndrome
  Prenatal Diagnosis, 2001
• Midgestational maternal urine steroid markers of fetal Smith–Lemli–Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency)
  Steroids, 1999
• Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism
  American Journal of Medical Genetics, 1998
• Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings
  American Journal of Medical Genetics, 1998
• Diagnosis of Inborn Errors of Metabolism from Blood Spots by Acylcarnitines and Amino Acids Profiling Using Automated Electrospray Tandem Mass Spectrometry
  Pediatric Research, 1995
• Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1995
• Cerebrotendinous xanthomatosis: A review of biochemical findings of the patient population in the netherlands
  Journal of Inherited Metabolic Disease, 1987
• Profiling steroid hormones and urinary steroids
  Journal of Chromatography B: Biomedical Sciences and Applications, 1986